GOLDENWELL BIOTECH, INC. - (GWLL)

10-K Filing Date: April 12, 2024
ITEM 1C. CYBERSECURITY

 

Risk Management and Strategy

 

We do not have any processes for assessing, identifying, and managing material risks from cybersecurity threats.

 

Risks from Cybersecurity Threats

 

To date, we have not yet experienced any cybersecurity threats or incidents that have materially affected or are reasonably likely to materially affect our business, financial condition or results of operations.

 

Governance

 

Our board of directors (the “Board”) is acutely aware of the critical nature of managing risks associated with cybersecurity threats given the significance of these threats to our operational integrity and stakeholder confidence.

 

Board Oversight

 

The Board has oversight of cybersecurity risks and bears the primary responsibility for this domain. The members of our Board do not have experience in enterprise risk management, compliance, corporate governance, technology, or finance to equipping them to oversee cybersecurity risks effectively.